US 9555041
Neprilysin inhibitors
granted A61KA61K31/41A61K31/415
Quick answer
US patent 9555041 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/41, A61K31/415, A61K31/4155, A61K31/4192